MARKET

SRPT

SRPT

Sarepta Therapeutics Inc
NASDAQ
16.78
-0.46
-2.81%
Pre Market: 16.76 -0.02 -0.12% 07:07 08/10 EDT
OPEN
16.87
PREV CLOSE
16.78
HIGH
17.26
LOW
16.47
VOLUME
2.63K
TURNOVER
0
52 WEEK HIGH
25.32
52 WEEK LOW
14.68
MARKET CAP
1.77B
P/E (TTM)
-10.0987
1D
5D
1M
3M
1Y
5Y
1D
Evercore ISI Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)
TipRanks · 1h ago
Weekly Report: what happened at SRPT last week (0803-0807)?
Weekly Report · 5h ago
Why Sarepta Therapeutics (SRPT) Is Up 12.9% After Cutting 2026 Guidance And Naming A New CEO
Simply Wall St · 8h ago
Sarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer
Simply Wall St · 2d ago
Unusually active option classes on open August 7th
TipRanks · 3d ago
Barclays Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)
TipRanks · 3d ago
Sarepta Therapeutics Balances Profit Gains With Revenue Strain
TipRanks · 3d ago
Sarepta Therapeutics (SRPT) Stock Rally Hinges On Profit Progress And Revenue Drop
Simply Wall St · 3d ago
More
About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, siRNA knockdown therapies, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. The Company has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS.

Webull offers Sarepta Therapeutics Inc stock information, including NASDAQ: SRPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRPT stock methods without spending real money on the virtual paper trading platform.